Recent reports of Anthropic pursuing a record IPO with Nvidia as a potential $10 billion anchor investor have anchored trader sentiment around the $1.75–$2.25 trillion range. The company’s May 2026 Series H round set a $965 billion private valuation, while annualized revenue run rate climbed from $47 billion to $65 billion by July amid strong Claude model adoption and enterprise demand. Confidential S-1 filing in June, secondary-market marks above $1.2 trillion, and plans for a late-September prospectus and mid-October roadshow ahead of November midterms reinforce expectations of a substantial step-up from the prior round. The $15 billion credit facility and 2028 revenue projections near $200 billion further support the current implied probabilities, though execution risks around timing and public-market reception remain.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato$1.75–$2.00T 44%
$2.00–$2.25T 33.9%
$1.50–$1.75T 20.7%
$1.25–$1.50T 2.3%
$51,396 Vol.
$51,396 Vol.
31 dic 2027
<$1.25T
1%
$1.25–$1.50T
2%
$1.50–$1.75T
21%
$1.75–$2.00T
44%
$2.00–$2.25T
34%
$2.25–$2.50T
2%
$2.50T+
2%
No IPO by December 31, 2027
1%
$1.75–$2.00T 44%
$2.00–$2.25T 33.9%
$1.50–$1.75T 20.7%
$1.25–$1.50T 2.3%
$51,396 Vol.
$51,396 Vol.
31 dic 2027
<$1.25T
$1,558 Vol.
1%
$1.25–$1.50T
$2,640 Vol.
2%
$1.50–$1.75T
$9,019 Vol.
21%
$1.75–$2.00T
$19,677 Vol.
44%
$2.00–$2.25T
$11,131 Vol.
34%
$2.25–$2.50T
$2,441 Vol.
2%
$2.50T+
$2,677 Vol.
2%
No IPO by December 31, 2027
$2,253 Vol.
1%
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Recent reports of Anthropic pursuing a record IPO with Nvidia as a potential $10 billion anchor investor have anchored trader sentiment around the $1.75–$2.25 trillion range. The company’s May 2026 Series H round set a $965 billion private valuation, while annualized revenue run rate climbed from $47 billion to $65 billion by July amid strong Claude model adoption and enterprise demand. Confidential S-1 filing in June, secondary-market marks above $1.2 trillion, and plans for a late-September prospectus and mid-October roadshow ahead of November midterms reinforce expectations of a substantial step-up from the prior round. The $15 billion credit facility and 2028 revenue projections near $200 billion further support the current implied probabilities, though execution risks around timing and public-market reception remain.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Mercato aperto: Aug 19, 2026, 9:45 AM ET
Volume
$51,396Data di fine
1 gen 2028Mercato aperto
Aug 19, 2026, 9:45 AM ETRisolutore
0x69c47De9D...This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.Recent reports of Anthropic pursuing a record IPO with Nvidia as a potential $10 billion anchor investor have anchored trader sentiment around the $1.75–$2.25 trillion range. The company’s May 2026 Series H round set a $965 billion private valuation, while annualized revenue run rate climbed from $47 billion to $65 billion by July amid strong Claude model adoption and enterprise demand. Confidential S-1 filing in June, secondary-market marks above $1.2 trillion, and plans for a late-September prospectus and mid-October roadshow ahead of November midterms reinforce expectations of a substantial step-up from the prior round. The $15 billion credit facility and 2028 revenue projections near $200 billion further support the current implied probabilities, though execution risks around timing and public-market reception remain.
This market will resolve according to the implied equity valuation of Anthropic at its initial public offering (IPO) price. Anthropic refers to Anthropic PBC or the corporate successor or parent holding company whose listing represents Anthropic's business.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
The IPO price will be the final offering price to the public as stated in the final prospectus filed with the U.S. Securities and Exchange Commission. Trading prices after listing, including the opening trade, intraday prices, or closing price on the first day of trading, will not be considered. Indicated or preliminary price ranges, including any ranges disclosed in earlier filings or amendments, will not be considered.
The IPO valuation will be determined in the following order of precedence: (1) the implied fully diluted valuation at the final IPO price, as stated in the final prospectus or in an official Anthropic announcement; (2) if no such figure is stated, the final IPO price per share multiplied by the total number of shares outstanding on a fully diluted basis as disclosed in the final prospectus, where the fully diluted count includes all outstanding shares of every class and all shares underlying outstanding options, restricted stock units, warrants, and convertible instruments, regardless of vesting or exercise status and without applying the treasury stock method; (3) if the fully diluted share count cannot be determined from the final prospectus, the implied fully diluted IPO valuation as reported by a consensus of credible reporting.
If the determined valuation falls exactly on a boundary between two ranges, this market will resolve to the higher range.
If Anthropic's IPO has not priced by December 31, 2027, 11:59 PM ET, the market will resolve to "No IPO by December 31, 2027". If the IPO prices by the deadline, the market will resolve according to the final prospectus even if it is published after the end date.
If Anthropic becomes publicly traded without a priced initial public offering, including through a direct listing or through a merger, acquisition, or absorption by an entity that is already publicly traded, this market will resolve to "No IPO by December 31, 2027".
The primary resolution source will be the final prospectus filed with the SEC; however, a consensus of credible reporting may also be used.
Volume
$51,396Data di fine
1 gen 2028Mercato aperto
Aug 19, 2026, 9:45 AM ETRisolutore
0x69c47De9D...Recent reports of Anthropic pursuing a record IPO with Nvidia as a potential $10 billion anchor investor have anchored trader sentiment around the $1.75–$2.25 trillion range. The company’s May 2026 Series H round set a $965 billion private valuation, while annualized revenue run rate climbed from $47 billion to $65 billion by July amid strong Claude model adoption and enterprise demand. Confidential S-1 filing in June, secondary-market marks above $1.2 trillion, and plans for a late-September prospectus and mid-October roadshow ahead of November midterms reinforce expectations of a substantial step-up from the prior round. The $15 billion credit facility and 2028 revenue projections near $200 billion further support the current implied probabilities, though execution risks around timing and public-market reception remain.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCorrelati
Will Anthropic's market cap be between $2.25T and $2.5T at market close on IPO day?
24%
La capitalizzazione di mercato di Anthropic sarà pari o superiore a 600 miliardi di dollari alla chiusura del mercato il giorno dell’IPO entro il 31 dicembre 2027?
96%
Sì
Will Anthropic’s market cap be 1.8T or greater at market close on IPO day by December 31 2027?
84%
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti